Author Question: Denormalization reduces the chance of errors introduced by normalizing relations. Indicate ... (Read 65 times)

neverstopbelieb

  • Hero Member
  • *****
  • Posts: 534
Denormalization reduces the chance of errors introduced by normalizing relations.
 
  Indicate whether the statement is true or false

Question 2

The use-case model is developed during the requirements analysis phase.
 
  Indicate whether the statement is true or false



AmberC1996

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

FALSE
Explanation: Denormalization can increase the chance of errors and inconsistencies that normalization avoided.
CL

Answer to Question 2

TRUE
Explanation: Use-case modeling is done in the early stages of system development (during the analysis phase) to help developers understand the functional requirements of the system without worrying about how those requirements will be implemented.
CL



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library